Advertisement

Reactions Weekly

, Volume 1733, Issue 1, pp 84–84 | Cite as

Bevacizumab/erlotinib

Skin and subcutaneous tissue disorders, malaise and hypertension: 7 case reports
Case report
  • 15 Downloads

Reference

  1. Chikaishi Y, et al. Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer. Annals of Translational Medicine 6: 401, No. 20, Oct 2018. Available from: URL: http://doi.org/10.21037/atm.2018.09.33 -JapanCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations